WeSearch

Remote Monitoring in Cirrhosis Could Reduce Admissions

·5 min read · 0 reactions · 0 comments · 53 views
Remote Monitoring in Cirrhosis Could Reduce Admissions
TL;DR · WeSearch summary

Remote monitoring for patients with advanced cirrhosis may help reduce emergency admissions by enabling earlier intervention. The CirrhoCare system integrates various technologies to facilitate continuous patient monitoring and communication with clinicians. A pilot study indicated a significant reduction in hospital admissions, highlighting the potential benefits of this approach.

Key facts
About this source

Medscape files mainly under health. We currently carry 231 of its stories.

Original article
Medscape
Read full at Medscape →

Story provenance

Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherMedscape
Canonical URLhttps://www.medscape.com/viewarticle/remote-monitoring-cirrhosis-could-reduce-admissions-2026a1000hwz?src=rss
Publication timeFri, 29 May 2026 08:48:37 EDT
Retrieval time2026-05-29T12:50:00.410Z
Last seen2026-05-29T12:50:00.410Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
Cluster_v0X5STByPnR
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

BARCELONA, Spain — Remote monitoring via wearables, app-based symptom reporting, and clinician dashboards could help shift care for patients with advanced cirrhosis from repeated emergency admissions toward earlier intervention in the community.Rajeshwar Prosad Mookerjee, MD, PhD, professor of translational hepatology at University College London and consultant hepatologist at the Royal Free Hospital, both in London, England, and colleagues developed CirrhoCare, a digital healthcare system designed for at-home monitoring and management of patients with decompensated cirrhosis.

Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from Medscape